Fresenius Medical Care continues to execute on turnaround plan and raises 2023 earnings outlook due to strong operational performance in first nine months and solid business outlook for the fourth quarter

Posted on by

Continued solid organic growth in Care Enablement and Care Delivery including sequentially stable same market treatment growth in the U.S. Successful execution on turnaround plan driving productivity improvements in Care Delivery and pricing in Care Enablement FME25 transformation savings…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.